Related Experiment Video
Updated: Mar 27, 2026

05:49
Mechano-Node-Pore Sensing: A Rapid, Label-Free Platform for Multi-Parameter Single-Cell Viscoelastic Measurements
Published on: December 2, 2022
3.3K
DNAzyme-Based Nanostructures for Dynamic Cell Regulation and Sensing
Haoyu Fan1, Xichen Du2, Ruocan Qian2
1International Elite Engineering School, East China University of Science and Technology, Shanghai, China.
Chemistryopen
|March 26, 2026
Summary
DNAzyme nanostructures offer advanced cellular regulation and biosensing. Integrating DNAzymes with nanomaterials enhances stability and performance for applications in imaging, therapy, and diagnostics.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- DNAzymes are catalytic DNA molecules with high stability and programmability.
- Traditional DNAzyme applications face limitations like nuclease susceptibility and poor cellular uptake.
- Nanomaterial integration offers solutions to enhance DNAzyme performance in biological systems.
Purpose of the Study:
- To review advancements in DNAzyme-based nanostructures for cellular regulation and biosensing.
- To explore innovations in DNAzyme-nanomaterial integration for improved functionality.
- To discuss the therapeutic and diagnostic potential of these advanced systems.
Main Methods:
- Systematic review of cutting-edge research on DNAzyme nanostructures.
- Analysis of DNAzyme integration with various nanomaterials (liposomes, gold nanoparticles, MOFs).
- Discussion of key innovations like logic-gated systems, rRNA-activated sensors, and nanodevices.
Main Results:
- DNAzyme-nanomaterial hybrids overcome limitations, showing enhanced stability and cellular uptake.
- Novel applications include programmable cell assembly, subcellular imaging, and amplified biosensing.
- DNAzyme nanostructures demonstrate potential in targeted gene silencing and cancer therapy.
Conclusions:
- DNAzyme-based nanostructures represent a significant advancement in dynamic cellular regulation and biosensing.
- These technologies hold promise for developing novel theranostic platforms and therapeutic strategies.
- Future directions focus on clinical translation through context-responsive and biocompatible designs.

